 |
When testing vancomycin for S. aureus on automated systems using FDA (rather than CLSI) interpretive criteria, all isolates with MICs of 4 mcg/ml should be analyzed more carefully for reduced susceptibility to vancomycin. Refer to the CDC algorithm for directions on workup: www.cdc.gov/nicdod/dhqp/ar_visavrsa_algo.html
DISCLAIMER
Askit is for general information purposes only and may not be relied upon by users for decisions or action in specific circumstances. Neither ASM nor the expert assures the accuracy or completeness of information provided. Questions are answered based on current information, which may change over time. Please note the date that a question was answered. If an answer is more than one year old, you may want to resubmit the question for an updated answer.
The advice and comments do not necessarily reflect the views of ASM. ASM and INDIVIDUAL experts expressly disclaim any and all liability for any direct, indirect, or special damages or loss of any nature incurred as a consequence of use of this site or any advice or comment by any expert. By using Askit, the user accepts the waiver of claims and all terms of use of ASM’s site, including the disclaimers set forth in the “Legal Rights” link on ASM’s home page.
|
